Analysis Of Direct Medical Costs In Hemodialysis Patients
DOI:
https://doi.org/10.55927/metropolis.v1i1.8444Keywords:
Cost, Hemodalys, CKDAbstract
Hemodialysis is a costly and lifelong treatment. The objective of this study is to ascertain the overall expenses associated with therapy for outpatient chronic kidney failure patients undergoing hemodialysis, from the standpoint of a hospital. Additionally, the study aims to identify any notable disparities between the actual therapy costs and the rates provided by INA-CBG for hemodialysis patients. The present study employs a non-experimental analytical approach, utilising a cross-sectional research methodology. The retrospective collection of data was conducted using the medical records of National Health Insurance (JKN). The hospital perspective indicates that the direct medical costs associated with hemodialysis for 69 outpatient patients with chronic kidney disease (CKD) for the period of October to December amount to IDR 70,129,389.00. A notable disparity exists between the actual expenses and the INA-CBG package rates for chronic kidney disease (CKD) patients receiving hemodialysis at N-3-15-0.
Downloads
References
Agustina, Palu, B., & Muchlis, N. (2020). Analysis of real costs and INA-CBG’s tariff at The Bahagia General Hospital in Makassar City. Journal of Muslim Community Health (JMCH), 1(2), 13–25.
Amalia, R. (2020). Analisis Penerapan Indonesia Case Based Groups (Ina-Cbg’s) Dalam Pelayanan Badan Penyelenggara Jaminan Sosial (BPJS) Kesehatan Di Rumah Sakit Kabupaten Pelalawan. Pekbis Jurnal, 12(2), 106–116.
Arriyani, F., & Wahyono, T. Y. M. (2023). Faktor Risiko Penyakit Ginjal Kronis pada Kelompok Usia Dewasa : Literature Review. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 6(5), 788–797. https://doi.org/10.56338/mppki.v6i5.3239
Azhari, M. S. (2020). Analisis Biaya Pasien Gagal Ginjal Kronik Dengan Anemia Di RSUD DR. Kanujoso Djatiwibowo Balikpapan. Universitas Islam Indonesia.
Dewi, T. S. (2018). Hubungan Gaya Hidup dengan Kejadian Gagal Ginjal Kronik di Rumah Sakit Pku Muhammadiyah Yogyakarta. Jurnal Fakultas Ilmu Keperawatan, 1–19.
Fauziah, Wahyono, D., & Budiarti, L. E. (2015). Cost of Illness Dari Chronic Kidney Disease dengan Tindakan Hemodialisis. Jurnal Manajemen Dan Pelayanan Farmasi, 5(3), 149–158.
Fibionisa, W., Ramadhan, Y., & Nugroho, M. N. (2023). Comparison Analysis of Rates by Unit Cost and INA-CBGs Rates in Hemodialysis Services at Hospital X. European Journal of Business and Management Research, 8(5), 108–114. https://doi.org/10.24018/ejbmr.2023.8.5.1872
KDIGO. (2013). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 3(1).
Laporan Riskesdas 2018 Nasional.pdf. (n.d.).
Leonard, D., Fitriani, Y., Wijayanto, T., Senopati, A. R. S., Fajriati, A. P., Yolanda, E., & Sumiyati, S. (2021). Sosialisasi Pelaksanaan Sistem INA-CBGs di Pelayanan Kesehatan. Jurnal Abdidas, 1(6), 842–846. https://doi.org/10.31004/abdidas.v1i6.222
Liu, P., Quinn, R. R., Lam, N. N., Elliott, M. J., Xu, Y., James, M. T., Manns, B., & Ravani, P. (2021). Accounting for Age in the Definition of Chronic Kidney Disease. JAMA Internal Medicine, 181(10), 1359–1366. https://doi.org/10.1001/jamainternmed.2021.4813
National Kidney Foundation. (2002). Clinical Practice Guidlines for chronic kidney disease: Evaluation, Classification and Stratification. In KDOQI. National Kidney Fondation.
National Kidney Foundation. (2022). Chronic Kidney Disease (CKD). https://www.kidney.org/atoz/content/about-chronic-kidney-disease
Permenkes. (2016). Peraturan Menteri Kesehatan Republik 64 Tahun 2016. 5(1), 1689–1699.
PERMENKES. (2013). Standar Tarif Pelayanan Kesehatan Pada Fasilitias Lanjutan Dalam Tingkat Pertama dan Fasilitas Kesehatan Tingkat Lanjutan Dalam Penyelenggaraan Program Jaminan Kesehatan. Menteri Kesehatan Republik Indonesia.
Pernefri. (2013). Konsesnsus Dialisis. In Journal of Chemical Information and Modeling (Vol. 53, Issue 9).
Rachmawati, E., Rosyida, & Norcahyanti, I. (2019). Perbandingan Biaya Riil Terhadap Tarif INA CBGs Tindakan Hemodialisis Pasien Gagal Ginjal Kronis Rawat Jalan di RSUD Dr. Abdoer Rahem Situbondo. 27.
Raymond R Tjandrawinata. (2016). Peranan Farmaekonomi dalam Penent uan Kebijakan yang Berkait an dengan Obat-Obat an. Buku Pedoman Farmakoekonomi, 15.
Rohenti, I. R., Rahmadaniati, H. U., & Sarnianto, P. (2019). Analisis Biaya Medis Langsung Pasien Hemodialisa di Rumah Sakit X Wilayah Bekasi. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 16(2), 386. https://doi.org/10.30595/pharmacy.v16i2.5731
Saputra, W. C., W.S, S. F. ., Advistasari, Y. D., & Munisih, S. (2020). Cost Of Illness Perawatan Pasien Gagal Ginjal Kronik di Instalasi Rawat Inap Rsi Sultan Agung Semarang. Jurnal Kesehatan Masyarakat, 19(2), 441–447. http://publikasi.dinus.ac.id/index.php/visikes/article/view/4196
Soetedja, S. V., Atik Nurwahyuni, & Amelia Intan. (2022). Biaya Pelayanan Hemodialisis Pasien Gagal Ginjal Kronis di Era JKN : Literature Review. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 5(10), 1213–1218. https://doi.org/10.56338/mppki.v5i10.2712
Tjokroprawira, A., Setiawan, P. B., Santoso, D., Soegiarto, G., & Rahmawati, L. D. (2015). Buku Ajar Ilmu Penyakit Dalam edisi 2 (2nd ed.). Airlangga University Press.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Elsa Mahardika Putri, Tantik Tandela, Okky Intan Mawarni, Anis Akhwan Dhafin, Fendy Prasetyawan
This work is licensed under a Creative Commons Attribution 4.0 International License.